Neurobiology Center and Program in Neurobiology, Department of Neurology, Children's Hospital Boston, Boston, Massachusetts, USA.
Nat Med. 2010 Nov;16(11):1241-7. doi: 10.1038/nm.2230. Epub 2010 Oct 14.
Despite substantial investment by the pharmaceutical industry over several decades, there has been little progress in developing new, efficacious and safe analgesics. As a result, many large pharmaceutical companies are leaving the area of pain medication. Nevertheless, the chances of success could increase if analgesic drug development strategy changed. To achieve such a paradigm shift we must understand why development of drugs for pain relief is so challenging.
尽管制药行业在过去几十年中投入了大量资金,但在开发新的、有效和安全的镇痛药方面几乎没有取得进展。因此,许多大型制药公司正在退出疼痛药物治疗领域。然而,如果改变镇痛药药物开发策略,成功的机会可能会增加。为了实现这种范式转变,我们必须了解为什么开发缓解疼痛的药物如此具有挑战性。